← Scroll for more →
AtriCure, Inc. (ATRC)
Surgical & Medical Instruments & Apparatus
Latest Price
$56.20
TTM P/E
267.62
Normalized P/E
--
Div Yield
--
Book Value
10.20
P/B Ratio
5.51
Valuation metrics
adjust assumptions →Base FCF: $25M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$38.76
31% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.47M | $125.0M | 8.80% | +431.9K | 2026-06-30 |
| Wellington Management Group LLP | 3.50M | $97.0M | 6.87% | +113.0K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3.13M | $87.0M | 6.15% | +424.6K | 2026-06-30 |
| Hood River Capital Management LLC | 2.91M | $81.0M | 5.71% | -212.2K | 2026-06-30 |
| Alliancebernstein L.P. | 2.77M | $78.0M | 5.44% | -490.5K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.19M | $61.0M | 4.31% | +34.6K | 2026-06-30 |
| Nomura Asset Management International Inc. | 1.73M | $48.0M | 3.41% | -70.6K | 2026-06-30 |
| Goldman Sachs Group Inc | 1.60M | $44.0M | 3.14% | -69.2K | 2026-06-30 |
| State Street Corp | 1.39M | $38.0M | 2.73% | +87.8K | 2026-06-30 |
| Marshall Wace, LLP | 1.33M | $37.0M | 2.62% | -133.6K | 2026-06-30 |